Virtual Event: The 340B drug discount program is at a crossroads. What’s next?

Editor’s note: A recording of the event is embedded below.

To advocates, this program supports safety net hospitals. Critics say some game the system.

As the Biden administration takes control, STAT looks at what’s next for this political football in a two part discussion.

Featured Speakers:

Part 1: A Q&A with Robert Charrow

• Robert Charrow, senior chair – health care and FDA practice, Greenberg Traurig
• Rachel Cohrs, Washington correspondent, STAT (moderator)

Part 2: A stakeholder panel discussion

• Ted Okon, MBA, executive director, Community Oncology Alliance
• Maureen Testoni, president and chief executive officer, 340B Health
• Vacheria Tutson, Esq., director, regulatory affairs, National Association of Community Health Centers
• Sylvia Yu, senior counsel for federal programs, PhRMA
• Rachel Cohrs, Washington correspondent, STAT (moderator)